NMN300MG Plus Resveratrol & PQQ
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| trans-Resvératrol Source : Resvératrol | 50 mg |
| Acide 1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylique, 4,5-dihydro-4,5-dioxo- Source : Pyrroloquinoline quinone disodium salt | 20 mg |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps (to) maintain/support the body's ability to metabolize nutrients. Helps in energy metabolism/(and) tissue formation. NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health. NMN is a NAD+ precursor which is a factor in normal growth and development. NMN is a NAD+ precursor which is an important cofactor in energy metabolism. Supports biological functions which play a key role in the maintenance of good health. (Provides) An antioxidant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- Vitaleyoumi Wellness Inc.
- NPN or DIN-HM
- 80143609
- Status
- Active licence
- Licence date
- 21 August 2025
- Revision date
- Not provided
- Form
- Capsule, dur
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80143609
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “NMN300MG Plus Resveratrol & PQQ”, https://compoatlas.com/en/supplements/canada/80143609-nmn300mg-plus-resveratrol-pqq, updated 21 August 2025.